Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Robert LeBoyer's Stock Ratings
Noble Capital Markets Analyst
Robert LeBoyer is an analyst at Noble Capital Markets. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/23/2025
Overall Average Return
0.22%
Smart Score
Overall Average Return Percentile
43rd
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/20/2025 | TNXP | Buy Now | Tonix Pharmaceuticals | $16.62 | 321.18% | Robert LeBoyer43% | $70 → $70 | Reiterates | Outperform → Outperform | Get Alert |
| 01/22/2025 | NTRB | Buy Now | Nutriband | $5.22 | 149.04% | Robert LeBoyer43% | → $13 | Initiates | → Outperform | Get Alert |
| 08/19/2024 | GOVX | Buy Now | Geovax Labs | $0.84 | 1090.48% | Robert LeBoyer43% | $6 → $10 | Maintains | Outperform | Get Alert |
| 02/14/2024 | UNCY | Buy Now | Unicycive Therapeutics | $0.64 | 843.25% | Robert LeBoyer43% | → $6 | Initiates | → Outperform | Get Alert |
| 12/18/2023 | CVKD | Buy Now | Cadrenal Therapeutics | $16.66 | -75.99% | Robert LeBoyer43% | → $60 | Initiates | → Outperform | Get Alert |
| 09/27/2023 | ELDN | Buy Now | Eledon Pharma | $3.45 | 189.86% | Robert LeBoyer43% | → $10 | Initiates | → Outperform | Get Alert |
| 05/08/2023 | GOVX | Buy Now | Geovax Labs | $0.84 | 614.29% | Robert LeBoyer43% | → $90 | Initiates | → Outperform | Get Alert |
| 02/21/2023 | MAIA | Buy Now | MAIA Biotechnology | $2.02 | 593.07% | Robert LeBoyer43% | → $14 | Initiates | → Outperform | Get Alert |
| 09/20/2022 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | Robert LeBoyer43% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/18/2022 | TNXP | Buy Now | Tonix Pharmaceuticals | $16.62 | -96.39% | Robert LeBoyer43% | → $384000 | Initiates | → Outperform | Get Alert |
| 10/12/2021 | AXLA | Buy Now | Axcella Health | — | — | Robert LeBoyer43% | → $150 | Initiates | → Outperform | Get Alert |
| 08/19/2021 | LCTX | Buy Now | Lineage Cell Therapeutics | $0.45 | 1697.75% | Robert LeBoyer43% | → $8 | Initiates | → Outperform | Get Alert |
| 01/25/2021 | PSTV | Buy Now | Plus Therapeutics | $1.10 | 623.98% | Robert LeBoyer43% | → $120 | Initiates | → Buy | Get Alert |
| 10/05/2020 | BNTC | Buy Now | Benitec Biopharma | $13.55 | — | Robert LeBoyer43% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/28/2020 | AVXL | Buy Now | Anavex Life Sciences | $9.60 | 25.07% | Robert LeBoyer43% | → $12 | Initiates | → Buy | Get Alert |
| 09/17/2020 | LCTX | Buy Now | Lineage Cell Therapeutics | $0.45 | — | Robert LeBoyer43% | — | Initiates | → Outperform | Get Alert |
| 08/24/2020 | CNSP | Buy Now | CNS Pharma | $0.91 | 1113.46% | Robert LeBoyer43% | → $825000 | Initiates | → Buy | Get Alert |
| 04/10/2018 | VTVT | Buy Now | vTv Therapeutics | $20.31 | — | Robert LeBoyer43% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/08/2018 | NTRP | Buy Now | Neurotrope | $2.71 | 453.51% | Robert LeBoyer43% | → $15 | Initiates | → Buy | Get Alert |
| 04/12/2017 | NTRP | Buy Now | Neurotrope | $2.71 | 1043.91% | Robert LeBoyer43% | → $31 | Initiates | → Buy | Get Alert |
